By: Forbes Real Time
July 01, 2013 at 10:28 AM EDT
The Best- And Worst-Performing Biotech Stocks In The First Half Of 2013
These are the biotechnology, medical device, and pharmaceutical stocks that did the best -- and the worst -- in the first half of the year. This screen only includes companies that had a market capitalization of at least $300 million at the beginning of the period, and that were traded on the New York Stock Exchange, the Nasdaq or the American Stock Exchange that had market capitalizations of more than $300 million as of a week ago. The data come from Interactive Data and Thomson Reuters Fundamentals via FactSet Research Systems.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here